BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $411,000 | +756.2% | 241,775 | +1381.6% | 0.00% | – |
| Q4 2018 | $48,000 | -78.3% | 16,318 | -14.6% | 0.00% | -100.0% |
| Q3 2017 | $221,000 | +32.3% | 19,118 | +33.3% | 0.00% | 0.0% |
| Q2 2017 | $167,000 | +15.2% | 14,339 | +34.8% | 0.00% | 0.0% |
| Q4 2016 | $145,000 | +23.9% | 10,637 | -15.3% | 0.00% | 0.0% |
| Q1 2016 | $117,000 | -91.6% | 12,564 | -79.1% | 0.00% | -90.0% |
| Q4 2014 | $1,387,000 | – | 60,220 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |